Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy

Retina

Volumn 31, Issue 10, 2011, Pages 1983-1987

  Brown, Jamin S ^a   Mahmoud, Tamer H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CLOPIDOGREL; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CILIARY DISK; DIABETIC PARS PLANA VITRECTOMY; DIABETIC RETINOPATHY; EYE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ANTICOAGULANTS; ASPIRIN; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; WARFARIN;

EID: 81155160155     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31821800cd     Document Type: Article

References (20)

1. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-1262.
2. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.
3. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-3453. (Pubitemid 16148410)
4. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-1412.
5. Godtfredsen J, Boysen G, Peterson P. Long term anticoagulation or antiplatelet treatment. Giving warfarin always depends on balancing risks. Br Med J 2001;323:234; author reply 235-236.
6. Schein OD, Friedman DS, Fleisher LA, et al. Anesthesia management during cataract surgery. Evid Rep Technol Assess (Summ) 2000:1-3.
7. Segal JB, McNamara RL, Miller MR, et al. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 2000;15:56-67. (Pubitemid 30060940)
8. Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 2000;28:419-422. (Pubitemid 32050928)
9. Saitoh AK, Saitoh A, Taniguchi H, Amemiya T. Anticoagulation therapy and ocular surgery. Ophthalmic Surg Lasers 1998;29:909-915.
10. Elaxel CJ, Blach RK. Aspirin is a hazard for vitreoretinal surgery. Br J Ophthalmol 1996;80:486.
11. Benzimra JD, Johnston RL, Jaycock P, et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye (Lond) 2009;23:10-16.
12. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003;110:1784-1788. (Pubitemid 37025439)
13. Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 2003;81:38-40. (Pubitemid 36621902)
14. Fu AD, McDonald HR, Williams DF, et al. Anticoagulation with warfarin in vitreoretinal surgery. Retina 2007;27:290-295. (Pubitemid 46398893)
15. Charles S, Rosenfield PJ. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007;27:813-815. (Pubitemid 47479373)
16. Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc 2006;104:149-160.
17. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number
18. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:757-765.
19. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:585-597.
20. Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing Snellen visual acuity measurements. Retina 2010; 30:1046-1050.